Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 262.91
+5.15 (2.00%)
Jul 31, 2026, 3:15 PM IST
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 6.22 billion as of July 31, 2026. Its market cap has increased by 198.56% in one year.
Market Cap
6.22B
Enterprise Value
6.57B
Revenue
1.51B
Ranking
n/a
PE Ratio
56.06
Stock Price
262.91
ChartMarket Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 6.22B, an increase of 57,054.34%. That is a compound annual growth rate of 168.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 6.22B | 74.44% |
| Dec 31, 2025 | 3.57B | 91.03% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solara Active Pharma Sciences | 24.74B |
| Beta Drugs | 22.53B |
| Indoco Remedies | 20.26B |
| Sakar Healthcare | 19.70B |
| Ind-Swift Laboratories | 19.45B |
| Windlas Biotech | 17.70B |
| Jagsonpal Pharmaceuticals | 15.22B |
| Sigachi Industries | 9.90B |